Literature DB >> 9477064

In vivo effects of dexmedetomidine on laser-Doppler flow and pial arteriolar diameter.

P Ganjoo1, N E Farber, A Hudetz, J J Smith, E Samso, J P Kampine, W T Schmeling.   

Abstract

BACKGROUND: The alpha2-adrenergic agonist dexmedetomidine alters global cerebral blood flow (CBF). However, few studies have investigated the action of dexmedetomidine on the cerebral microcirculation. This investigation examined the effects of dexmedetomidine on (1) regional CBF in the rat cerebral cortex using laser-Doppler flowmetry and (2) on pial arteriolar diameter.
METHODS: Halothane-anesthetized rats were fitted with instruments to measure CBF as determined by laser-Doppler flow (CBFldf) or to measure pial arteriolar diameter by preparing a cranial hollow deepened until a translucent plate of skull remained, thereby maintaining the integrity of the cranial vault. In both groups, 20 microg/kg dexmedetomidine was infused intravenously. Thirty minutes later, the mean arterial pressure was restored to control values with an infusion of phenylephrine (0.5 to 5 microg/kg/min).
RESULTS: Administration of dexmedetomidine was associated with decreases in end-tidal and arterial carbon dioxide. The CBFldf and pial arteriolar diameter were measured during normocapnia (controlled carbon dioxide) and during dexmedetomidine-induced hypocapnia. Intravenous administration of dexmedetomidine significantly decreased systemic arterial pressure concurrent with a decrease in CBFldf (22% in normocapnic animals, 36% in hypocapnic animals). Restoration of mean arterial pressure increased CBFldf in normocapnic but not in hypocapnic animals. Similarly, dexmedetomidine significantly reduced pial vessel diameter in both normocapnic (9%) and hypocapnic animals (17%). However, vessel diameters remained decreased in the normocapnic and hypocapnic animals after the mean arterial pressure was restored.
CONCLUSIONS: These results suggest a modulation of cerebral vascular autoregulation by dexmedetomidine which may be mediated, in part, by alterations in carbon dioxide. Dexmedetomidine may have a direct action on the cerebral vessels to reduce the CBF during normo- or hypocapnia. The differences between CBFldf and pial arteriole responses to restoration of mean arterial pressure may reflect the difference in measurement techniques because laser-Doppler measurements reflect the net effect of several arterial segments on microvascular perfusion, whereas diameter measurements specifically examined individual pial arterioles, suggesting that dexmedetomidine vasoconstriction in the cerebral vasculature may be differentially and regionally mediated.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9477064     DOI: 10.1097/00000542-199802000-00022

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  21 in total

Review 1.  Anesthesia and the quantitative evaluation of neurovascular coupling.

Authors:  Kazuto Masamoto; Iwao Kanno
Journal:  J Cereb Blood Flow Metab       Date:  2012-04-18       Impact factor: 6.200

2.  Modeling of region-specific fMRI BOLD neurovascular response functions in rat brain reveals residual differences that correlate with the differences in regional evoked potentials.

Authors:  Christopher P Pawela; Anthony G Hudetz; B Douglas Ward; Marie L Schulte; Rupeng Li; Dennis S Kao; Matthew C Mauck; Younghoon R Cho; Jay Neitz; James S Hyde
Journal:  Neuroimage       Date:  2008-03-04       Impact factor: 6.556

3.  Differential effect of isoflurane, medetomidine, and urethane on BOLD responses to acute levo-tetrahydropalmatine in the rat.

Authors:  Xiping Liu; Rupeng Li; Zheng Yang; Anthony G Hudetz; Shi-Jiang Li
Journal:  Magn Reson Med       Date:  2011-12-28       Impact factor: 4.668

4.  Post-operative dexmedetomidine-based sedation after uneventful intracranial surgery for unruptured cerebral aneurysm: comparison with propofol-based sedation.

Authors:  Hiroshi Yokota; Kazuhiro Yokoyama; Hiroshi Noguchi; Toshikazu Nishioka; Osamu Umegaki; Hisao Komatsu; Toshisuke Sakaki
Journal:  Neurocrit Care       Date:  2011-04       Impact factor: 3.210

5.  Enhancement of resting-state fcMRI networks by prior sensory stimulation.

Authors:  Chenxuan Li; Zhixin Li; B Douglas Ward; Melinda R Dwinell; Julian H Lombard; Anthony G Hudetz; Christopher P Pawela
Journal:  Brain Connect       Date:  2014-11

6.  Quasi-periodic patterns (QPP): large-scale dynamics in resting state fMRI that correlate with local infraslow electrical activity.

Authors:  Garth John Thompson; Wen-Ju Pan; Matthew Evan Magnuson; Dieter Jaeger; Shella Dawn Keilholz
Journal:  Neuroimage       Date:  2013-09-23       Impact factor: 6.556

7.  A protocol for use of medetomidine anesthesia in rats for extended studies using task-induced BOLD contrast and resting-state functional connectivity.

Authors:  Christopher P Pawela; Bharat B Biswal; Anthony G Hudetz; Marie L Schulte; Rupeng Li; Seth R Jones; Younghoon R Cho; Hani S Matloub; James S Hyde
Journal:  Neuroimage       Date:  2009-03-12       Impact factor: 6.556

8.  Effects of the α₂-adrenergic receptor agonist dexmedetomidine on neural, vascular and BOLD fMRI responses in the somatosensory cortex.

Authors:  Mitsuhiro Fukuda; Alberto L Vazquez; Xiaopeng Zong; Seong-Gi Kim
Journal:  Eur J Neurosci       Date:  2012-10-29       Impact factor: 3.386

9.  Dynamic resting state fMRI analysis in mice reveals a set of Quasi-Periodic Patterns and illustrates their relationship with the global signal.

Authors:  Michaël E Belloy; Maarten Naeyaert; Anzar Abbas; Disha Shah; Verdi Vanreusel; Johan van Audekerke; Shella D Keilholz; Georgios A Keliris; Annemie Van der Linden; Marleen Verhoye
Journal:  Neuroimage       Date:  2018-02-15       Impact factor: 6.556

10.  Pial arteries respond earlier than penetrating arterioles to neural activation in the somatosensory cortex in awake mice exposed to chronic hypoxia: an additional mechanism to proximal integration signaling?

Authors:  Yuta Sekiguchi; Hiroyuki Takuwa; Hiroshi Kawaguchi; Takahiro Kikuchi; Eiji Okada; Iwao Kanno; Hiroshi Ito; Yutaka Tomita; Yoshiaki Itoh; Norihiro Suzuki; Ryo Sudo; Kazuo Tanishita; Kazuto Masamoto
Journal:  J Cereb Blood Flow Metab       Date:  2014-07-30       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.